7,540.95

-39.12

-0.52%

51,992.20

+221.89

+0.43%

25,152.43

-284.57

-1.12%

2,810.59

-1.26

-0.04%

4.8940

-0.0350

-0.71%

21.74

+2.32

+11.96%

3,954.00

+55.10

+1.41%

76,577.69

-1,207.67

-1.55%

Crude Oil Dec 26

95.91

-8.21

-7.89%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqGM - Nasdaq Real Time Price USD

Neuphoria Therapeutics Inc. (NEUP)

3.0000 -0.0500 (-1.64%)

As of 3:25:10 PM EST. Market Open.

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Scancell completes up to US$25 million in debt financing, providing optionality alongside equity investment to finance iSCIB1+ phase 3 development

GlobeNewswire 1mo ago

SCLP.L

NEUP
-0.98%
BLK
Neuphoria Responds to the announcement made by London-listed Scancell Holdings plc

GlobeNewswire 4mo ago

SCLP.L

NEUP
-0.98%
Lynx1 Sends Open Letter to Fellow Neuphoria Shareholders

PR Newswire 10mo ago

NEUP
-0.98%
Scancell and Neuphoria Therapeutics Announce Merger Agreement and Financing

GlobeNewswire 3mo ago

NEUP
-0.98%
SCLP
Leading Advisory Firms Recommend Voting FOR Lynx1's Independent Nominees

PR Newswire 10mo ago

NEUP
-0.98%
Leading Proxy Advisory Firm ISS Recommends that Shareholders Vote the WHITE Proxy Card FOR Both of Neuphoria’s Director Nominees

GlobeNewswire 10mo ago

NEUP
-0.98%
Neuphoria Responds to Lynx1’s Revised Indication of Interest at a Reduced Price and Premium

GlobeNewswire 10mo ago

NEUP
-0.98%
Neuphoria Provides Facts, Exposes False Narratives in Response to Lynx1 Fictions

GlobeNewswire 10mo ago

NEUP
-0.98%

Performance Overview

Return	NEUP	S&P 500 (^GSPC)
YTD	-22.68%	+10.51%
1-Year	-34.07%	+10.59%
3-Year	-89.50%	+75.20%

Mobilize your Website

View Site in Mobile | Classic

Share by: